Cure Day Hospitals Holdings Company

About Cure Day Hospitals

About Cure Day Hospitals

Cure Day Hospitals was established 16 years ago by a group of visionary doctors whose dream it was to provide private health care that is more affordable and more accessible to South Africans. South Africa’s private health care has been criticised for its high costs with medical inflation at the core of these spiralling expenses. Cure Day Hospitals’ business model addresses this by providing lower pricing to benefit both medical aid members and private patients.

To contribute to Cure Day Hospitals’ legacy, a Black Economic Empowerment (BEE) Partnership was formed. Cure Day is wholly owned by doctors and business people and is supported by an experienced and qualified management team.

The group’s first day hospital was bought as a going concern. Established 32 years ago, it reopened as Medkin Cure Day Hospitals in March 2008. The second hospital opened in May 2011 in Midstream and more facilities followed.

The group now consists of 12 day hospitals in total, with 6 based in Gauteng in the Pretoria CBD (Medkin), Midstream, Erasmuskloof, Fourways, Wilgeheuwel and Newmarket Alberton; Bloemfontein, Free State and Western Cape: Foreshore, Somerset West, Bellville, and Paarl. We have recently established our first footprint in the Eastern Cape in East London with further new developments which will include Cure Day Hospitals Mbombela and more to come.

The vision of the Cure Day Holdings board of directors is to establish a footprint across South Africa in a timely manner to ensure minimum risk and a healthy cash flow for the group.

What to Expect at a Day Hospital

A day hospital is a facility where surgery is performed and patients discharged on the same day.

Surgical procedures are performed using modern technology and minimal invasive surgical techniques. This expedites recovery and reduces time spent in hospital.

Specialists perform only minor procedures in a safe and well-equipped environment. Anaesthetists administer anaesthetics with trained operating theatre nursing staff supporting the doctors.

This approach to surgery is highly cost effective for patients.

Our Partners

Our Directors

Vusi Mahlangu

Chairman – Cure Day Hospitals Group

Vusi is a founder and director of Tamela Holdings (Pty) Ltd, a black-owned investment company, and has more than 24 years’ experience in investment banking.

He has a BSc in Chemical Engineering (Honours) from the University of Cape Town and an MBA from Harvard Business School.

Vusi is serving on various boards, amongst others Capitec.

Bert von Wielligh


Bert von Wielligh has a BComm Accounting and an MBA, both from the University of Pretoria.  His career includes hospital and operations management for the Medforum, Curamed and Mediclinic hospital groups.  He was the MD of the Curamed Group (Medforum General and Heart Hospital, Pretoria Heart Hospital, Muelmed, Astrid, Pretoria Gynaecological Hospital, and Kloof Hospital) and  was instrumental in Mediclinic acquiring shareholding of Curamed.  He also served as operational director for Mediclinic’s Tshwane Region.  He is now the CEO of Cure Day Hospitals and plans to grow the group to a national footprint.  Bert’s experience includes involvement with the National Hospital Network (NHN) and the Hospital Association of South Africa (HASA).

Dr André Roux


Dr André Roux, MB BCh (Wits), DA(SA), FFA(SA), FANZCA is a specialist anaesthesiologist and director of the Pretoria-based Brink Anaesthetists.  He previously worked in Johannesburg and Australia and is a Fellow of the Australian and New Zealand College of Anaesthetists.

He is also a member of the South African Society of Anaesthetists’ Private Practice Business Unit as well as a committee member of HITSA (Health Improvement Teams South Africa), a multidisciplinary group promoting management principles in healthcare.

He completed the Management Advancement Programme at Wits Business School and is a director of Precision Medical Solutions, a medical practice management firm with a national footprint, as well as various other companies and has a long involvement with medical finance and day hospital management.  He is one of the founders of the Cure Day Hospitals Group and initiated the annual Cure Day Hospitals Community Project.

He is currently chairman of the Cure Day Hospitals New Business Committee.

Dr Oscar Shimange

BOARD MEMBER, Specialist Obstetrician and Gynaecologist

Dr Oscar Shimange (MBChB (Natal), DTM & H, DPH, DOH (Wits), Dip for Med (SA), AMP (MBS), FCOG (SA), MBA (UFS)) is a specialist obstetrician and gynaecologist. He is member of several professional organisations, including: The South African Medical Association, South African Society of Obstetricians and Gynaecologists, South African Menopause Society (SAMS), the South African Society for Ultrasound in Obstetrics and Gynaecology (SASUOG), the  International Society for Ultrasound in Obstetrics and Gynaecology (ISUOG), North American Menopause Society, International Society of Gynaecological Endoscopy (ISGE), the Southern African Society of Gynaecological Endoscopy (SASGE) (a founder member), and the International Menopause Society (IMS).
Dr Shimange is a practising specialist with an MBA (UFS).

Also an accredited mediator with MIM and UCT. Completed an introductory programme in medicolegal practice with SAMLA and UCT.

Previously served on the following organisations:
Council member of the College of Obstetricians and Gynaecologists of the Colleges of Medicine of South Africa, board member of the Medical and Dental Board of the HPCSA.  Board member of Curamed Holdings, a subsidiary of Mediclinic Southern Africa. Completed a board leadership programme in finance for non-financial managers with the Gordon Institute of Business Science. A member of The Institute of Directors of South Africa (IODSA). Also completed a programme in Corporate Governance with the same institution.

Former Group Chairman Cure Day Hospitals (PTY) Ltd for 13years.

Jannie Prinsloo

Non-Executive Independent Director

Jannie attained B Com (Hons) in Accountancy and Certificate in the Theory of Accountancy (CTA) from the University of Pretoria. He qualified as a Chartered Accountant (SA) in 1976 and was appointed as an equity partner and director by PricewaterhouseCoopers (PwC) in 1979 until his retirement in 2011 (32 years).Over the years Jannie manage a significant audit practice of prestigious clients, including leading companies in the healthcare industry a number of large international pharmaceutical companies, higher education institutions – University of Pretoria, Monash and De Montfort International Universities – and the SA National Parks Board. Jannie initiated and developed the Healthcare Division of PwC in Southern Africa and eventually represented SA at the global firm’s Health Division cluster meetings.

Subsequent to retirement at PwC, Jannie has been appointed as a Non-executive Independent Director of Cure Day Hospitals Holdings, and Chairperson of the Audit & Risk Committee of the Company. Jannie has also been appointed as Independent Expert of Audit & Risk Committees of the Medical Schemes: BONITAS (Chair), PROFMED (Chair) & ANGLO (Chair). Jannie is also an independent trustee member of Keystone Retirement Annuity Fund and a Finance Committee member of the Joint Municipal Pension Fund..

Dr Paul Leuschner

Ear, Nose & Throat Surgeon

Dr Paul Leuschner earned his MB ChB at the University of Pretoria in 1996. He graduated from the University of Pretoria in 2003 as an ear, nose & throat surgeon MMed (L et O). He has been in private practice in Pretoria since 2004.

Anton Millar

Board Member

Anton Millar, B Bus Sci (Hons) (UCT), HDip Acc (WITS), CA(SA), CFA is the Principal and founder of TSC Capital, a private investment and advisory entity primarily focusing on arranging, advising, participating in and managing private equity investments. Key investment focus areas are financial services, healthcare and technology sectors. TSC Capital also manages investments outside of South Africa that are held in various venture capital investments in the HealthTech and FoodTech industries.

Prior to TSC Capital, Anton was Managing Director, responsible for the Corporate and Investment Banking Division in South Africa at Absa Capital then a subsidiary of Barclays Bank. Previously he was joint head of Specialised Finance for South Africa at Investec Bank.

Dr Imraan Tayob

Anaesthetist and board member

Imraan qualified as a medical doctor in 2000 and as a specialist anaesthesiologist in 2007.

He joined the Northern Anaesthetic Group and went into full time private practice in 2008.

He served on the executive committee of AIPA(Anaesthesiologist Independant Practice Association) for over 5 years and is currently a member of the South African Society of Anaesthesiologists. Imraan also manages the Sunninghill Pain Clinic. 

He completed the Financial management principles course at USB in 2019 and is currently the Chairman of Cure Day Hospitals Fourways and is a member of the IOD(SA). 


Dr Molefe Matima

dentist and Board member

Dr Molefe Matima L.D.T.(SA); BDS(MEDUNSA); DIP. ODONT.- M.F.O.S.(UP) is a dentist with a special interest in Dental Implantology, Trauma Management and Minor Oral Surgery in general.
He is a founding member and first President of the Dental Professionals Association (DPA).

He has delivered numerous lectures to his peers on the DPA forum as well as at Cure Day Hospitals Medkin, even prior to its inception, and is HPCSA CPD-accredited. Dr Matima also serves on the Disciplinary Committee of the HPCSA as a dentist since 2016 to date.

Dr Matima is presently a part-time lecturer and clinician at the department of Maxillo Facial & Oral Surgery at Sefako Makgatho University of Health Sciences.

He has served as Chairman of the Cure Day Hospitals Medkin board since 2008.

Koert Pretorius


Koert holds a BCompt in Accounting Science from the University of the Free State and a Master of Business Leadership from Unisa. He joined Mediclinic in 1998 as Regional Manager for the central region of operations in Southern Africa. In 2003, he assumed the role of Chief Operating Officer of the Mediclinic Group. His leadership and dedication were further recognised when he was appointed CEO of the Southern Africa operations in 2008. He also served as an executive director of Mediclinic International Limited from 2006 until the acquisition of Al Noor Hospitals Group plc. In April 2022, he assumed the position of Group Chief Operating Officer, marking yet another significant milestone in his illustrious career.

Koert also served as a member of the board of directors of the Mediclinic Group under the new private ownership structure until his retirement from Mediclinic on 31 March 2024. In addition to his professional achievements, Koert held numerous previous board positions and is actively involved as a founding member of the newly established Healthcare Advisory Network and is a trustee of the Ring for Peace Cape Trust, an initiative dedicated to addressing Gender-Based Violence (GBV).

Exco members

Bert von Wielligh


Mmamoko Lamola

Group HR manager

Johan Nel


Nicola van der Westhuizen


Sorita van Tonder

Group Marketing Manager

Albert De Jongh

New Business Development Manager

Group Patient Satisfaction Survey

We value our patients feedback. See how we rated nationally in May 2024.

Patients have the opportunity to score: Poor/Average/Good/Excellent.

Service received from Reception

Excellent Rating

Nursing care

Excellent Rating

Discharge Information

Excellent Rating

Ease of finding hospital location

Excellent Rating

Cleanliness of facility

Excellent Rating

Likeliness to recommend facility

Excellent Rating

South Africa’s Protection of Personal Information Act (POPIA) & Cookie Consent

We will not sell, share, or rent your Personal Information to any third party or use your email address for unsolicited mail. Any emails sent by us will only be in connection with the provision of our services and/or the marketing thereof. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By continuing in the website you accept the use of cookies.